iOmx Therapeutics AG
Industry / private company
Location:
München,
Germany (DE)
Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation (2022)
Sorrentino A, Menevse AN, Michels T, Volpin V, Durst FC, Sax J, Xydia M, et al.
Journal article
CAMK1D triggers immune resistance of human tumor cells refractory to anti-PD-L1 treatment (2020)
Volpin V, Michels T, Sorrentino A, Menevse AN, Knoll G, Ditz M, Milenkovic VM, et al.
Journal article